Skip to main content
. 2020 Apr 6;4(2):pkaa001. doi: 10.1093/jncics/pkaa001

Figure 4.

Figure 4.

Modeled estimates of the relative contributions of overdiagnosed and clinically significant cases in black and white persons with A) papillary thyroid cancer using a 65% overall estimated overdiagnosis rate and B) ER/PR+ breast cancer (women only) using a 30% overall estimated overdiagnosis rate. ER/PR+ = estrogen receptor/progesterone receptor positive. Rates listed are per 100 000 age-adjusted population.